Search Within

Results 1 - 25 of 25

A Novel Design of Combining the Angiotensin Converting Enzyme (ACE) Inhibitor Captopril with the Angiotensin Receptor Blocker (ARB) Losartan Using Homo Coupling via PEG Diacid Linker

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 8,Issue: 3
Page: 221-225
Authors: Mehrnoosh Hashemzadeh, Shery Park, Hee Ju and Mohammad R. Movahed

The Application of Angiotensin Converting Enzyme Inhibitors in Heart Surgery

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 2
Page: 105-108
Authors: Yasuyuki Shimada

Radioligands for the Angiotensin II Subtype 1 (AT1) Receptor

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 16
Page: 1585-1599
Authors: William B. Mathews and Zsolt Szabo

Angiotensin Converting Enzyme Inhibitors and Cardiopulmonary Bypass: Is ACE Inhibitor Safe for Heart Surgery?

Journal: Current Enzyme Inhibition
Volume: 1,Issue: 3
Page: 253-256
Authors: Yasuyuki Shimada and Hideshi Itoh

Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 2
Page: 75-78
Authors: Akira Miyajima, Eiji Kikuchi, Takeo Kosaka and Mototsugu Oya

Angiotensin Converting Enzyme Inhibitor in Coronary Artery Bypass Surgery

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2,Issue: 7
Page: 495-500
Authors: Yasuyuki Shimada and Fumio Yamamoto

The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders

Journal: Current Clinical Pharmacology
Volume: 9,Issue: 1
Page: 2-9
Authors: Sergio Henrique Sousa Santos and Ana Cristina Simoes e Silva

Substituted Benzimidazole Derivatives as Angiotensin II -AT1 Receptor Antagonist: A Review

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10,Issue: 14
Page: 1366-1384
Authors: V. K. Vyas and M. Ghate

Blockade of the Renin-Angiotensin-Aldosterone System: Effects on Hypertensive Target Organ Damage

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4,Issue: 3
Page: 219-228
Authors: Anna M Grandi and Andrea M. Maresca

Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 12
Page: 1199-1214
Authors: Rajko Igic and Rahim Behnia

Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System

Journal: Current Diabetes Reviews
Volume: 4,Issue: 1
Page: 63-78
Authors: G. Neil Thomas and Brian Tomlinson

Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy

Journal: Current Pharmacogenomics
Volume: 2,Issue: 2
Page: 157-162
Authors: I. Narita and F. Gejyo

Angiotensin II Type I Receptor Blocker and Endothelial Function in Humans: Role of Nitric Oxide and Oxidative Stress

Journal: Current Medicinal Chemistry-Cardiovascular & Hematological Agents
Volume: 3,Issue: 2
Page: 133-148
Authors: Yukihito Higashi, Kazuaki Chayama and Masao Yoshizumi

Impact of Inhibitors of the Renin-Angiotensin-Aldosterone System on Liver Fibrosis and Portal Hypertension

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 30
Page: 3649-3661
Authors: U. Tox and H. M. Steffen

Angiotensin-Converting Enzyme Inhibitors in Veterinary Medicine

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 13
Page: 1347-1361
Authors: H. P. Lefebvre, S. A. Brown, V. Chetboul, J. N. King, J.-L. Pouchelon and P. L. Toutain

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 4
Page: 473-481
Authors: George S. Stergiou and Irini I. Skeva

The Renin-Angiotensin System: The Role of Inhibitors, Blockers, and Genetic Polymorphisms in the Treatment and Prevention of Heart Failure

Journal: Current Vascular Pharmacology
Volume: 1,Issue: 1
Page: 33-39
Authors: Patricia R. Hebert, JoAnne M. Foody and Charles H. Hennekens

The Future of Angiotensin II Inhibition in Cardiovascular Medicine

Journal: Current Drug Target -Cardiovascular & Hematological Disorders
Volume: 5,Issue: 1
Page: 15-30
Authors: Pascal Meier, Marc Maillard and Michel Burnier

Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 27
Page: 4572-4580
Authors: Robert L. Chevalier

Angiotensin Converting Enzyme (ACE) Inhibitory Peptides: Production and Implementation of Functional Food

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 31
Page: 3622-3643
Authors: F. De Leo, S. Panarese, R. Gallerani and L. R. Ceci

Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 11
Page: 1090-1094
Authors: Hiroshi Yoshida, Giuseppe Rosano, Mitsuyuki Shimizu, Seibu Mochizuki and Michihiro Yoshimura

Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 13
Page: 1307-1316
Authors: Agostino Molteni, Lisa F. Wolfe, William F. Ward, C. Hsin Ts'ao, Loredana Brizio Molteni, Patricia Veno, Brian L. Fish, Joan M. Taylor, Norma Quintanilla, Betty Herndon and John E. Moulder

Cytostatic Properties of Some Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type I Receptor Antagonists

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 9
Page: 751-761
Authors: Agostino Molteni, William F. Ward, Chung H. Ts'ao, JoAnn Taylor, William Small Jr., Loredana Brizio-Molteni and Patricia A. Veno

Results 1 - 25 of 25